Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 13.98
(-1.48%)
CNY 13.98
(-1.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 54.14 Million | 70.98 Million | 122.39 Million | 103.83 Million | 92.54 Million | 32.27 Million |
| Net Income | 31 Million | -327.66 Million | 50.73 Million | 41.36 Million | -490.75 Million | 35.11 Million |
| Depreciation & Amortization | 34.96 Million | 33.04 Million | 38.8 Million | 28.17 Million | 31.21 Million | 25.96 Million |
| Deferred income taxes | -1.88 Million | 21.57 Million | 13.78 Million | -930.52 Thousand | 3.07 Million | -26.22 Million |
| Stock-based compensation | - | - | - | - | 43.7 Million | - |
| Change in working capital | -22.58 Million | 16.51 Million | -2.14 Million | -824.76 Thousand | 18.95 Million | -66.53 Million |
| Other non-cash items | 105.17 Million | 349.08 Million | 35 Million | 35.12 Million | 533.12 Million | 37.73 Million |
| Investing Cash Flow | -51.11 Million | -40.02 Million | 2.69 Million | -12.61 Million | -1.05 Million | 2.53 Million |
| Investments in PPE | -53.91 Million | -41.17 Million | -4.71 Million | -2.9 Million | -6.32 Million | -33.64 Million |
| Acquisitions | 2.8 Million | -738.67 Thousand | -149.64 Thousand | 262.5 Thousand | -1.21 Million | 168.86 Thousand |
| Investment purchases | - | 738.67 Thousand | -8.83 Million | -9.99 Million | -15 Million | -17.1 Million |
| Sales/Maturities of investments | - | 1.89 Million | 11.5 Million | 2.92 Million | 21.48 Million | 50 Million |
| Other Investing Activities | 2.8 Million | -738.67 Thousand | 4.89 Million | -2.9 Million | - | 3.11 Million |
| Financing Cash Flow | -27.32 Million | -70.64 Million | -121.77 Million | -74.41 Million | -58.19 Million | -213.53 Million |
| Debt repayment | -17.5 Million | -107.1 Million | -153.25 Million | -218.25 Million | -163 Million | -175 Million |
| Dividends payments | -1.2 Million | -3.67 Million | -6.97 Million | -14.16 Million | -14.92 Million | -29.29 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.61 Million | 40.13 Million | 38.44 Million | 158 Million | 119.72 Million | -9.23 Million |
| Accounts receivables | 11.11 Million | 40.05 Million | 14.17 Million | 9.87 Million | 24.65 Million | -11.62 Million |
| Accounts payables | -27.86 Million | -54.3 Million | -15.12 Million | 21.64 Million | 5.05 Million | -6.09 Million |
| Inventory | -5.83 Million | 9.19 Million | -14.97 Million | -31.4 Million | -13.83 Million | -22.59 Million |
| Other working capital | -29.75 Million | 21.57 Million | 13.78 Million | -930.52 Thousand | 3.07 Million | -43.94 Million |
| Cash at beginning of period | 126.28 Million | 159.3 Million | 156.2 Million | 139.57 Million | 104.73 Million | 280.59 Million |
| Cash at end of period | 105.13 Million | 120.31 Million | 159.3 Million | 156.2 Million | 139.57 Million | 104.73 Million |
| Capital Expenditure | -53.91 Million | -41.17 Million | -4.71 Million | -2.9 Million | -6.32 Million | -33.64 Million |
| Effect of forex changes on cash | 77.01 Thousand | 694.39 Thousand | -209.18 Thousand | -182.87 Thousand | 1.53 Million | 2.85 Million |
| Net cash flow / Change in cash | -21.14 Million | -38.99 Million | 3.1 Million | 16.62 Million | 34.84 Million | -175.86 Million |
| Free Cash Flow | 231.14 Thousand | 29.8 Million | 117.68 Million | 100.93 Million | 86.22 Million | -1.37 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.68 Million | 5.75 Million | 14.39 Million | 31 Million | -10.26 Million | 10.52 Million |
| Depreciation & Amortization | - | 6.18 Million | 6.18 Million | 34.96 Million | 9.08 Million | 9.08 Million |
| Deferred income taxes | - | - | - | -1.88 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -34.06 Million | - | -22.58 Million | 5.28 Million | 7.57 Million |
| Other non-cash items | -10.12 Million | 24.33 Million | -3.52 Million | 105.17 Million | -9.84 Million | -2.63 Million |
| Investing Cash Flow | -7.74 Million | -17.48 Million | -34.62 Million | -51.11 Million | -27.07 Million | -14.21 Million |
| Investments in PPE | -1.68 Million | -17.62 Million | -34.62 Million | -53.91 Million | -30.96 Million | -14.22 Million |
| Acquisitions | -3.18 Million | 3000.00 | - | 2.8 Million | 2.8 Million | 1.08 Million |
| Investment purchases | -3 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6.06 Million | 135.97 Thousand | - | 2.8 Million | 1.08 Million | -1.08 Million |
| Financing Cash Flow | 13.6 Million | 6.39 Million | 15.79 Million | -27.32 Million | 3.24 Million | -12.21 Million |
| Debt repayment | -15.5 Million | -9 Million | -17.7 Million | -17.5 Million | -6 Million | -36 Million |
| Dividends payments | -676.53 Thousand | -565.93 Thousand | -448.95 Thousand | -1.2 Million | -184.45 Thousand | -252.79 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.21 Million | 894.79 Thousand | -1.9 Million | -8.61 Million | 9.43 Million | 24.04 Million |
| Accounts receivables | - | -37.98 Million | - | 11.11 Million | 11.11 Million | 2.11 Million |
| Accounts payables | - | - | - | -27.86 Million | - | - |
| Inventory | - | 3.92 Million | - | -5.83 Million | -5.83 Million | 5.45 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 101.02 Million | 96.72 Million | 105.13 Million | 126.28 Million | 131.68 Million | 127.96 Million |
| Cash at end of period | 104.34 Million | 109.74 Million | 96.72 Million | 105.13 Million | 105.13 Million | 131.24 Million |
| Capital Expenditure | -1.68 Million | -17.62 Million | -34.62 Million | -53.91 Million | -30.96 Million | -14.22 Million |
| Effect of forex changes on cash | -92.6 Thousand | 88.76 Thousand | -26.82 Thousand | 77.01 Thousand | 658.27 Thousand | -1.05 Million |
| Net cash flow / Change in cash | 3.32 Million | 13.01 Million | -8.4 Million | -21.14 Million | -26.54 Million | 3.28 Million |
| Free Cash Flow | -4.12 Million | 6.28 Million | -23.75 Million | 231.14 Thousand | -36.7 Million | 10.32 Million |
VIPRF
BBT
MYN
600724
ONEGLOBAL
FAR